Loading...
BioPlus Acquisition Corp.
BIOS•NASDAQ
Financial ServicesShell Companies
$10.79
$-0.01(-0.05%)
BioPlus Acquisition Corp. (BIOS) Stock Overview
Explore BioPlus Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for BIOSStats details for BIOS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BIOSAnalyst Recommendations details for BIOS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
CEO
Mr. R. Ross Haghighat
Headquarters
260 Madison Avenue, New York, NY
Founded
2022